Gore Recognized as one of the Worlds Best Multinational Workplaces by Great Place to Work®
Company earns No. 3 spot
Company earns No. 3 spot
Partnership latest step in Gore’s ongoing commitment to improve quality of care for hernia patients
Over 5,000 patients from 114 worldwide sites provide a unique perspective of real-world conditions
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
Final study results demonstrate for the first time efficacy of long-lasting absorbable biosynthetic mesh in challenging hernia repairs; has potential to end biologics era in hernia repair
Pivotal Multicenter Investigational Study Begins at Medical University of South Carolina (MUSC), Evaluating Safety and Efficacy of Innovative GORE® Carotid Stent
Hybrid of unique bioabsorbable and permanent materials provide a single-stage hernia repair to help minimize complications in preperitoneal applications
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.
Charing Cross International Symposium